Aspyra taps Schutt as new CEO
Rodney Schutt has joined Aspyra, a provider of clinical and diagnostic information solutions for the healthcare industry, as CEO, effective Nov. 17.
Schutt brings more than 22 years of experience in the business, healthcare and technology fields to Aspyra, most recently as the chief operating officer for Luminetx, a provider of bioscience technologies based in Memphis, Tenn.
Before working with Luminetx, the Calabassas, Calif.-based Aspyra said that Schutt was vice president of business development and global commercial operations for Smith and Nephew Orthopaedics, and held various positions at GE Healthcare.
Jim Zierick, who had been interim CEO since February, will remain as an active director on the Aspyra board, the company said. Schutt has also been appointed to serve on the Aspyra board of directors.
Schutt brings more than 22 years of experience in the business, healthcare and technology fields to Aspyra, most recently as the chief operating officer for Luminetx, a provider of bioscience technologies based in Memphis, Tenn.
Before working with Luminetx, the Calabassas, Calif.-based Aspyra said that Schutt was vice president of business development and global commercial operations for Smith and Nephew Orthopaedics, and held various positions at GE Healthcare.
Jim Zierick, who had been interim CEO since February, will remain as an active director on the Aspyra board, the company said. Schutt has also been appointed to serve on the Aspyra board of directors.